FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2456-2457 December 2, 2004 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: In 1979, we reported the results of treating 19 patients who had acute myelogenous leukemia in first remission with intensive chemotherapy, radiation therapy, and transplantation of allogeneic marrow from HLA-identical siblings between March 1976 and March 1978.¹ These patients had been treated with cyclophosphamide, total-body irradiation (one exposure of 920 cGy), and prophylaxis with methotrexate for graft-versus-host disease (GVHD). Five patients died from interstitial pneumonia within six months of transplantation, one patient relapsed and died at one year, and one died at one year with septicemia complicating chronic GVHD. Four patients were alive with minimal chronic GVHD, . . . [Full Text of this Article]

This article has been cited by other articles:

• Devetten, M, Armitage, J. (2007). Hematopoietic cell transplantation: progress and obstacles. Ann Oncol 18: 1450-1456 [Abstract] [Full Text]